Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Annals of Neurology|June 26, 2024
COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with RituximabFredrik Piehl, Peter Alping, Suvi Virtanen, et al.Annals of Clinical and Translational Neurology|August 22, 2022
COVID-19 clinical outcomes and DMT of MS patients and population-based controlsElisa Longinetti, Hannah Bower, Kyla A McKay, et al.The Lancet Regional Health. Europe|May 27, 2024
Morbidity and mortality among children, adolescents, and young adults with cancer over six decades: a Swedish population-based cohort study (the Rebuc study)Margaretha Stenmarker, Panagiotis Mallios, Elham Hedayati, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 25, 2023
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort studyThomas Silfverberg, Christina Zjukovskaja, Per Ljungman, et al.Frontiers in Molecular Biosciences|September 15, 2022
RNA-sequencing and mass-spectrometry proteomic time-series analysis of T-cell differentiation identified multiple splice variants models that predicted validated protein biomarkers in inflammatory diseasesRasmus Magnusson, Olof Rundquist, Min Jung Kim, et al.The Lancet. Neurology|July 16, 2022
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trialAnders Svenningsson, Thomas Frisell, Joachim Burman, et al.Science Translational Medicine|November 13, 2015
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseasesMika Gustafsson, Danuta R Gawel, Lars Alfredsson, et al.Pageof 8